Literature DB >> 8260720

Sexing of in vitro-fertilized preimplantation mouse embryos by the PCR method.

T Yano1.   

Abstract

The applicability of the dual PCR method to embryo sexing was examined with the aim of establishing a noninvasive method of preimplantation diagnosis for human genetic disorders. Mouse pre-embryos obtained by in vitro fertilization were studied. The Sry gene sequence and the myogenin sequence were amplified as the Y-specific and internal control sequences, respectively. Amplification of as little as 10 pg of mouse genomic DNA was possible with the dual PCR method, the sensitivity being 10-fold greater than that of the single PCR method. The sex was identified in 100% (24/24) and 96% (23/24) of the pre-embryos tested at the 16- and 4-cell stages, respectively. In addition, the sex of all four single blastomeres dissociated from 4-cell pre-embryos agreed in 76% (16/21) of the specimens tested and 94% (79/84) of dissociated blastomeres could be sexed. The sex of single blastomeres biopsied from pre-embryos at the 8-cell stage could be identified. After transfer of 13 male and 25 female sexed pre-embryos, six viable fetuses were obtained. Histological examination showed that all these fetuses were of the predicted sex. Sexing of biopsied single blastomeres by the dual PCR method was rapid and reliable, suggesting its feasibility for preimplantation diagnosis of in vitro fertilized human pre-embryos.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260720     DOI: 10.1007/BF01874138

Source DB:  PubMed          Journal:  Jpn J Hum Genet        ISSN: 0916-8478


  2 in total

1.  Influence of mosaicism on sexing of human preembryos detected by the polymerase chain reaction.

Authors:  Y Katagiri; S Katayama
Journal:  J Assist Reprod Genet       Date:  1996-08       Impact factor: 3.412

2.  Genetic sex determination assays in 53 mammalian species: Literature analysis and guidelines for reporting standardization.

Authors:  Karin Hrovatin; Tanja Kunej
Journal:  Ecol Evol       Date:  2017-12-13       Impact factor: 2.912

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.